Enhancement of peripheral opioid analgesia following tissue injury or inflammation in animal models is well-documented, but clinical results of peripheral opioid therapy remain inconsistent. Previous studies in the central nervous system have shown that co-administration of l-and d-opioid receptor agonists can enhance analgesic outcomes; however, less is known about the functional consequences of opioid receptor interactions in the periphery. The present study examines the effects of intraplantar injection of the land d-opioid receptor agonists, morphine and deltorphin, alone and in combination on behavioral tests of nociception in naïve rats and on potassium-evoked release of CGRP from sciatic nerves of naïve rats. Neither drug alone affected nociceptive behaviors or CGRP release. Two separate measures of mechanical nociceptive sensitivity remained unchanged after co-administration of the two drugs. In contrast, when deltorphin was co-injected with morphine, dose-dependent and peripherally restricted increases in paw withdrawal latencies to radiant heat were observed. Similarly, concentration-dependent inhibition of CGRP release was observed when deltorphin and morphine were administered in sequence prior to potassium stimulation. However, no inhibition was observed when morphine was administered prior to deltorphin. All combined opioid effects were blocked by co-application of antagonists. Deltorphin exposure also enhanced the in vivo and in vitro effects of another l-opioid receptor agonist, DAMGO.
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Together, these results suggest that under normal conditions, d-opioid receptor agonists enhance the effect of l-opioid receptor agonists in the periphery, and local co-administration of d-and l-opioid receptor agonists may improve results of peripheral opioid therapy for the treatment of pain.
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Introduction
Systemic and central administration of opioids for the treatment of pain is sometimes accompanied by serious adverse side effects, and tolerance often occurs with prolonged use. The abuse potential and legal restrictions of this drug class can also limit their clinical usage. The targeting of peripheral opioid receptors may provide pain relief while reducing many of these limitations. Peripherally applied opioids have little or no analgesic effect under normal conditions, but it is well-established that peripheral opioid receptor function is enhanced after tissue injury or inflammation [23, 37, 40, 44] . Several mechanisms appear to contribute to improved peripherally mediated opioid analgesia during inflammation, including increased synthesis and transport of opioid receptors to the periphery [17, 21] , enhanced G-protein coupling [47] , and increased permeability of the perineurium [2] (for review see [38] ).
Recent studies have indicated that the efficacy of peripherally applied opioids can be improved in the absence of a complex or time-consuming inflammatory response. Peripheral l-and d-opioid receptors have both been shown to undergo functional upregulation following relatively brief exposure to a single inflammatory mediator, such as bradykinin or a protease activated receptor-2 agonist. This rapid process of enhancing peripheral opioid receptor function has been referred to as priming [4, 5, 26, 27, 33] . The priming requirement for functional competence has also been demonstrated for the d-opioid receptor in vivo [33] .
Despite overwhelming evidence from animal studies suggesting that the efficacy of peripherally restricted opioids should be high after tissue insult, clinical results of peripheral opioid therapy remain inconsistent. For example, topical morphine has been shown to reduce nociceptive behaviors in rats and dogs [39, 45] as well as pain scores in humans [10] following corneal injury. In contrast, many studies examining the efficacy of local morphine administration after arthroscopic knee surgery have failed to observe significant pain relief. Clinical reviews have concluded that this strategy provides little to no analgesic effect [15, 32] and similar conclusions have been drawn for other opioids and procedures [28] . One strategy that has proven to be effective in improving pain relief 
